Entecavir combined with interferon‐α Is superior to entecavir monotherapy in reducing hepatic and extrahepatic cancer in patients with chronic hepatitis B-Reference-Cited by-同舟云学术

Entecavir combined with interferon‐α Is superior to entecavir monotherapy in reducing hepatic and extrahepatic cancer in patients with chronic hepatitis B

Published:2021-10-08 Issue:3 Volume:128 Page:558-569
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Cheng Kailiang¹,Chen Yu²³,Wang Xiaomo¹,Xu Manman²³,Liao Wei¹,Duan Xiaoman⁴,Zhao Xinyu¹,Sun Yuanyuan¹,Duan Zhongping²³,Wang Li¹^ORCID

Affiliation:

1. Department of Epidemiology and Biostatistics Institute of Basic Medical Sciences Chinese Academy of Medical Sciences/School of Basic Medicine, Peking Union Medical College Beijing China

2. Fourth Department of Liver Disease (Difficult and Complicated Liver Diseases and Artificial Liver Center) Beijing You'an HospitalCapital Medical University Beijing China

3. Beijing Municipal Key Laboratory of Liver Failure and Artificial Liver Treatment Research Beijing China

4. Sam Houston State University Huntsville Texas

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cncr.33949

Reference37 articles.

1. Burden of liver diseases in the world

2. Associations Between Hepatitis B Virus Infection and Risk of All Cancer Types

3. Incidence of extrahepatic cancers among individuals with chronic hepatitis B or C virus infection: A nationwide cohort study

4. Incidence of hepatocellular carcinoma in chronic hepatitis B patients receiving nucleos(t)ide therapy: A systematic review

5. Baseline characteristics and treatment patterns of the patients recruited to the China Registry of Hepatitis B;Shan S;J Clin Transl Hepatol,2019

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Interim analysis of the PARADISE study: Benefits of add-on peginterferon-α in NA-treated patients with CHB;Antiviral Research;2024-06

2. Functional cure is associated with younger age in children undergoing antiviral treatment for active chronic hepatitis B;Hepatology International;2024-02-20

3. Causal associations of BAFF-R on IgD+ CD24- B cell immune cell trait with hepatocellular carcinoma and the mediating role of phenylacetylglutamate levels: a Mendelian randomization study;Journal of Cancer;2024

4. Clinical Survey of Different Treatment Methods for Chronic Viral Hepatitis B;Advances in Clinical Medicine;2023